AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Gallagher, WM Greene, LM Ryan, MP Sierra, V Berger, A Laurent-Puig, P Conseiller, E
Citation: Wm. Gallagher et al., Human fibulin-4: analysis of its biosynthetic processing and mRNA expression in normal and tumour tissues, FEBS LETTER, 489(1), 2001, pp. 59-66

Authors: Naumann, U Kugler, S Wolburg, H Wick, W Rascher, G Schulz, JB Conseiller, E Bahr, M Weller, M
Citation: U. Naumann et al., Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene,kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand, CANCER RES, 61(15), 2001, pp. 5833-5842

Authors: Gallagher, WM Argentini, M Sierra, V Bracco, L Debussche, L Conseiller, E
Citation: Wm. Gallagher et al., MBP1: a novel mutant p53-specific protein partner with oncogenic properties, ONCOGENE, 18(24), 1999, pp. 3608-3616

Authors: de Fromentel, CC Gruel, N Venot, C Debussche, L Conseiller, E Dureuil, C Teillaud, JL Tocque, B Bracco, L
Citation: Cc. De Fromentel et al., Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments, ONCOGENE, 18(2), 1999, pp. 551-557

Authors: Mary, MN Venot, C de Fromentel, CC Debussche, L Conseiller, E Cochet, O Gruel, N Teillaud, JL Schweighoffer, F Tocque, B Bracco, L
Citation: Mn. Mary et al., A tumor specific single chain antibody dependent gene expression system, ONCOGENE, 18(2), 1999, pp. 559-564

Authors: Venot, C Maratrat, M Sierra, V Conseiller, E Debussche, L
Citation: C. Venot et al., Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53 transactivation subdomains, ONCOGENE, 18(14), 1999, pp. 2405-2410
Risultati: 1-6 |